Tackling pharmaceutical pollution amongst many stakeholders.
Action points of the Implementation Programme 2018-2022:
Development and authorisation
– Developing ‘green’ medicines
– Making environmental information available
– Environmental classification of medicines
Prescription and use
– Radiographic contrast media task force
– Potential for improvement by hospitals
– Psychotropics task force
– Knowing about pharmaceutical residues
– Tackling cytostatic residues
– Disposal of liquid medicines
Waste and sewage treatment
– Collecting pharmaceutical waste
– Learning by doing at sewage treatment plants
– Sewage treatment plants of the future
– Insight into hospital discharges
– Impact on drinking water supply
Measures across the chain
– National approach with regional impact
– Insight into impact
– Communication
– Citizen science
– Impact of the Dutch approach in Europe
– Clarity concerning veterinary medicines
HCWH Europe gratefully acknowledges the financial support of the European Commission (EC)’s LIFE+ programme, the Federal Ministry for the Environment, Nature Conservation, and Nuclear Safety (BMU) Germany, and the German Environment Agency (UBA). HCWH Europe is solely responsible for the content of this project and related materials. The views expressed do not reflect the official views of the EC, BMU, or UBA.



